JWH-209

JWH-209

File:JWH-209 structure.png
IUPAC Name:	{{{IUPACName}}}
Other Names:
Identifiers
CAS Number
PubChem
ChemSpider
SMILES
InChI
InChIKey
StdInChI
StdInChIKey
Properties
Chemical formula	CHNO
Appearance
Density
Melting Point
Boiling Point
Solubility
Hazards
Main Hazards
Flash Point
Autoignition Temperature

JWH-209 is a synthetic cannabinoid that acts as a potent agonist at the CB1 and CB2 cannabinoid receptors. It is part of the naphthoylindole family of compounds, which were originally developed for research purposes to study the endocannabinoid system.

Chemical Structure and Properties

JWH-209 is chemically classified as a naphthoylindole, which is a subclass of synthetic cannabinoids. The compound's full chemical name is (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-1-ol. It has a molecular formula of C25H34O2 and a molecular weight of 366.54 g/mol.

The structure of JWH-209 includes a naphthoyl group attached to an indole core, which is a common feature among synthetic cannabinoids. This structure allows JWH-209 to bind effectively to cannabinoid receptors, mimicking the effects of naturally occurring cannabinoids such as tetrahydrocannabinol (THC).

Pharmacology

JWH-209 acts as a full agonist at both the CB1 and CB2 receptors, with a higher affinity for the CB1 receptor. This receptor is primarily found in the central nervous system, which explains the psychoactive effects associated with cannabinoids. The CB2 receptor is more commonly found in the immune system, and its activation is associated with anti-inflammatory effects.

The binding of JWH-209 to these receptors results in the modulation of neurotransmitter release, leading to effects such as altered perception, mood changes, and potential therapeutic effects such as pain relief.

Legal Status

The legal status of JWH-209 varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. It is often included in legislation targeting synthetic cannabinoids, which are frequently sold as "legal highs" or "herbal incense."

Health Effects and Risks

The use of JWH-209, like other synthetic cannabinoids, can pose significant health risks. These compounds can be much more potent than natural cannabinoids, leading to severe side effects such as anxiety, paranoia, tachycardia, and in some cases, psychosis. Long-term use may also lead to dependence and withdrawal symptoms.

Research and Applications

JWH-209, along with other synthetic cannabinoids, has been used in scientific research to better understand the endocannabinoid system and its role in various physiological processes. However, due to its potential for abuse and adverse effects, its use is generally restricted to controlled laboratory settings.

Also see

• Synthetic cannabinoids
• Endocannabinoid system
• CB1 receptor
• CB2 receptor
• JWH-018
• Tetrahydrocannabinol